HealthLeaders Media September 23, 2022
Robin Robinson

The massive infusion puts Verily in a good deal-making position as the health-tech arena grows.


– The infusion will support Verily’s initiatives in data platforms and research and technology that individualize healthcare.

– Analysts have compared Verily’s funding to Amazon’s acquisition of One Medical – both strategies increase their footprints in the healthcare technology market.

– Verily CEO Andy Conrad will become executive chairman of the Verily Board and current president Stephen Gillett will advance to CEO, effective January 2023.

Verily Life Sciences plans to use its newest $1 billion investment round, led by its parent company, Alphabet, to support expanding its focus on precision health, which includes initiatives in real world evidence generation, healthcare data platforms, and...

Today's Sponsors


Today's Sponsors

Upfront Healthcare

Today's Sponsor

Curation Health

Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Dr Melissa O'Connor: Lack of Funding, Clinical Research Among Barriers Limiting Technology Use in Home Health
Maven Clinic Announces $90 Million Series E Round of Funding Amidst Seismic Changes in Women’s and Family Health
AI will continue to attract investment in near future in the healthcare industry
Health management platform Novi Health raises $5M in Series A funding round
What Home-Based Care Providers Should Know About How Private Equity Firms Think